Back to search

United States· US:10967-683_471d8efe-566c-5c53-e063-6394a90aa84f

FLAWLESS FUTURE SPF 30

A medicinal product containing octinoxate; oxybenzone; octisalate; avobenzone, registered in United States by REVLON.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedFLAWLESS FUTURE SPF 30ATC—REGISTER NO.US:10967-683_471d8efe…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
OCTINOXATE; OXYBENZONE; OCTISALATE; AVOBENZONE
Manufacturer
REVLON
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    1096768317
    50 g in 1 JAR (10967-683-17)
  • ndc11
    10967-683-17

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Octinoxate; oxybenzone; octisalate; avobenzone in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All octinoxate; oxybenzone; octisalate; avobenzone products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b84560aa-91e7-422a-90c7-ee7d53710499
GET /v1/drugs/b84560aa-91e7-422a-90c7-ee7d53710499?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "TOPICAL",
  "source": "ndc",
  "strength": "7.14; 4; 4.75; 3",
  "substance": "OCTINOXATE; OXYBENZONE; OCTISALATE; AVOBENZONE",
  "productndc": "10967-683",
  "dosage_form": "EMULSION",
  "dea_schedule": null,
  "strength_unit": "mg/g; mg/g; mg/g; mg/g",
  "application_number": "M020",
  "marketing_category": "OTC MONOGRAPH DRUG"
}

See everything about octinoxate; oxybenzone; octisalate; avobenzone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.